Veeva Systems (WBO:VEEV) EBITDA: €852 Mil (TTM As of Apr. 2026)


WBO:VEEV Veeva Systems Inc WBO:VEEV
93 GF Score
Price €148.25
GF Value €246.73
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Veeva Systems EBITDA?

Veeva Systems WBO:VEEV +5.25% 93 EBITDA is €852 Mil as of Apr. 2026. GuruFocus rates WBO:VEEV with a GF Score™ of 93/100 and a GF Value™ of €246.73 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Veeva Systems's EBITDA for the three months ended in Apr. 2026 was €243 Mil. Its EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 was €852 Mil.

During the past 12 months, the average EBITDA Growth Rate of Veeva Systems was 22.80% per year. During the past 3 years, the average EBITDA Growth Rate was 25.00% per year. During the past 5 years, the average EBITDA Growth Rate was 15.90% per year. During the past 10 years, the average EBITDA Growth Rate was 24.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA Growth Rate using EBITDA data.

During the past 13 years, the highest 3-Year average EBITDA Growth Rate of Veeva Systems was 118.90% per year. The lowest was 4.30% per year. And the median was 32.60% per year.

Veeva Systems's EBITDA per Share for the three months ended in Apr. 2026 was €1.47. Its EBITDA per share for the trailing twelve months (TTM) ended in Apr. 2026 was €5.08.

During the past 12 months, the average EBITDA per Share Growth Rate of Veeva Systems was 21.30% per year. During the past 3 years, the average EBITDA per Share Growth Rate was 23.90% per year. During the past 5 years, the average EBITDA per Share Growth Rate was 15.00% per year. During the past 10 years, the average EBITDA per Share Growth Rate was 22.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBITDA per share growth rate using EBITDA per Share data.

During the past 13 years, the highest 3-Year average EBITDA per Share Growth Rate of Veeva Systems was 137.10% per year. The lowest was 3.70% per year. And the median was 29.30% per year.

Veeva Systems  (WBO:VEEV) EBITDA Explanation

EBITDA is a cash flow measure that ignores changes in working capital. EBITDA minus Depreciation, and Amortization (DA) equals Operating Income. Operating Income is profit before interest and taxes. Of course, Interest and taxes need to be paid.

While depreciation and amortization expenses do not need to be paid in cash, assets - especially tangible assets - do need to be replaced over time. EBITDA is not a measure of profit in any sense. EBITDA is a measure of cash generation by a business where the uses of that cash may be more or less discretionary depending on the nature of the business.

The EBITDA of a TV station is largely discretionary. Owners may use much of the EBITDA generated by a TV station as they see fit. The EBITDA of a railroad is largely non-discretionary. Owners must use much of the EBITDA generated by a railroad to replace the physical assets of the railroad or the business will literally fall apart over time.

EBITDA can be thought of as the cash a business generates that is available to:

Add more inventory
Add more receivables
Replace property, plant, and equipment
Add more property, plant, and equipment
Pay interest
Pay taxes
And finally: pay owners

EBITDA is widely used in financial analysis because Depreciation and Amortization are not present day cash expenses.. Depreciation and amortization are the spreading out of the costs of assets over the time in which those assets provide benefits. Today's depreciation and amortization expenses relate to assets bought in the past. The assets being expensed may or may not need to be replaced in the future. And the cost to replace the assets may be more or less than it was in the past. For this reason, the depreciation and amortization expenses a company records in the present year may have no relationship to the actual cash costs needed to maintain its assets in future years.

A company's depreciation expense depends on both its expectations about the assets it owns and its choice of accounting methods. Two companies owning identical assets may have different depreciation expenses because they have different expectations about the useful lives of those assets and because they make different accounting choices.

Analysts use EBITDA to remove this element of personal choice from a company's accounting statements. The use of EBITDA is an attempt to make the results of different companies more comparable and uniform.


Be Aware

Although depreciation is not a cash cost it is a real business cost because the company has to pay for the fixed assets when they purchase them. Both Warren Buffett and Charlie Munger hate the idea of EBITDA because in this calculation, depreciation is not counted as an expense.

EBITDA over Revenue is a good metric for comparing the operating efficiencies between companies because EBITDA is less vulnerable to companies' accounting choices. For this reason, EBITDA is used in ranking the Predictability of Companies. Also Price-to-EBITDA is sometimes used in valuations.


Veeva Systems EBITDA Related Terms


Veeva Systems EBITDA Historical Data

* Premium members only.

The historical data trend for Veeva Systems's EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Veeva Systems EBITDA Chart

Veeva Systems Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25 Jan26
EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 471.12 453.06 424.08 705.97 812.14

Veeva Systems Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 216.76 176.57 215.23 216.32 243.42

WBO:VEEV vs BTSG, TEM, HQY: EBITDA Comparison

For the Health Information Services subindustry, Veeva Systems's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Veeva Systems EV-to-EBITDA vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Veeva Systems's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Veeva Systems's EV-to-EBITDA falls into.


WBO:VEEV
93GF Score
Veeva Systems Inc WBO:VEEV
EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Veeva Systems's EBITDA for the fiscal year that ended in Jan. 2026 is calculated as

Veeva Systems's EBITDA was directly provided by GuruFocus' data source Morningstar. For the fiscal year ended in Jan. 2026, Veeva Systems's EBITDA was €812 Mil.

Veeva Systems's EBITDA for the quarter that ended in Apr. 2026 is calculated as

Veeva Systems's EBITDA was directly provided by GuruFocus' data source Morningstar. For the quarter ended in Apr. 2026, Veeva Systems's EBITDA was €243 Mil.

EBITDA for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €852 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sometimes companies may have already deducted Depreciation and Amortization from Gross Profit. In this case Depreciation and Amortization needs to be added back when calculating EBITDA.

Frequently Asked Questions Learn more about EBITDA →
What does a EBITDA of €852 Mil mean?
Veeva Systems (WBO:VEEV) has a EBITDA of €852 Mil as of Apr. 2026. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Veeva Systems.
Is Veeva Systems' EBITDA too high?
Veeva Systems' current EBITDA is €852 Mil. Overall, Veeva Systems has a GF Score™ of 93/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Veeva Systems' EBITDA compare to BTSG and TEM?
Veeva Systems' EBITDA of €852 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA for a Healthcare Providers & Services company?
A good EBITDA depends on the Healthcare Providers & Services industry context. However, EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA mean?
A high EBITDA can signal that a stock is expensive relative to its fundamentals. Ebitda is the difference between operating revenue and operating expenses not including depreciation and amortization. View historical data on Veeva Systems. Veeva Systems's current EBITDA is €852 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Veeva Systems stock overvalued right now?
Based on GuruFocus' analysis, Veeva Systems (WBO:VEEV) is currently considered Significantly Undervalued. The stock's GF Value™ is €246.73, compared to a current price of €148.25 — trading 39.9% below its estimated fair value. The current EBITDA is €852 Mil. Veeva Systems' overall GF Score™ is 93/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA calculated?
EBITDA is calculated from a company's financial statements. For Veeva Systems (WBO:VEEV), the current EBITDA is €852 Mil as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Veeva Systems (WBO:VEEV) Overvalued in 2026?

Based on GuruFocus' analysis, Veeva Systems stock appears to be undervalued. The current stock price of €148.25 is trading 39.9% below its estimated GF Value™ of €246.73. GuruFocus considers Veeva Systems to be Significantly Undervalued.

Key valuation signals for WBO:VEEV:

  • EBITDA: €852 Mil
  • GF Value™: €246.73 vs. price of €148.25 (39.9% below fair value)
  • GF Score™: 93/100 with 1 warning sign

No single metric tells the full story. See the WBO:VEEV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Veeva Systems Business Description

Address 4280 Hacienda Drive, Pleasanton, CA, USA, 94588
Veeva is the global leading supplier of cloud-based software solutions for the life sciences industry. The company's best-of-breed offerings address operating and regulatory requirements for customers ranging from small, emerging biotechnology companies to departments of global pharmaceutical manufacturers. The company leverages its domain expertise to improve the efficiency and compliance of the underserved life sciences industry, displacing large, highly customized and dated enterprise resource planning systems that have limited flexibility. Its two main products are Veeva CRM, a customer relationship management platform for companies with a salesforce, and Veeva Vault, a content management platform that tackles various functions within any life sciences company.
93GF Score

Get the complete analysis for WBO:VEEV

EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€148.25
Price
€246.73
GF Value